Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.
Beulens JW, Patel A, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, Lu J, McG Thom SA, Grobbee DE, Stolk RP; AdRem project team; ADVANCE management committee. Beulens JW, et al. Among authors: cruickshank jk. Diabetologia. 2009 Oct;52(10):2027-36. doi: 10.1007/s00125-009-1457-x. Epub 2009 Jul 25. Diabetologia. 2009. PMID: 19633827 Free article. Clinical Trial.
Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus.
Stolk RP, Vingerling JR, Cruickshank JK, Hughes AD, Stanton A, Juming L, Patel A, Thom SA, Grobbee DE; AdRem project team and ADVANCE management committee. Stolk RP, et al. Among authors: cruickshank jk. Contemp Clin Trials. 2007 Jan;28(1):6-17. doi: 10.1016/j.cct.2006.08.011. Epub 2006 Sep 3. Contemp Clin Trials. 2007. PMID: 17030155 Free article. Clinical Trial.
Retinal vascular lesions in patients of Caucasian and Asian origin with type 2 diabetes: baseline results from the ADVANCE Retinal Measurements (AdRem) study.
Stolk RP, van Schooneveld MJ, Cruickshank JK, Hughes AD, Stanton A, Lu J, Patel A, Thom SA, Grobbee DE, Vingerling JR; AdRem Project Team and ADVANCE Management Committee. Stolk RP, et al. Among authors: cruickshank jk. Diabetes Care. 2008 Apr;31(4):708-13. doi: 10.2337/dc07-1657. Epub 2008 Jan 9. Diabetes Care. 2008. PMID: 18184903 Free article.
Excess pressure integral predicts cardiovascular events independent of other risk factors in the conduit artery functional evaluation substudy of Anglo-Scandinavian Cardiac Outcomes Trial.
Davies JE, Lacy P, Tillin T, Collier D, Cruickshank JK, Francis DP, Malaweera A, Mayet J, Stanton A, Williams B, Parker KH, McG Thom SA, Hughes AD. Davies JE, et al. Among authors: cruickshank jk. Hypertension. 2014 Jul;64(1):60-8. doi: 10.1161/HYPERTENSIONAHA.113.02838. Epub 2014 May 12. Hypertension. 2014. PMID: 24821941 Free PMC article. Clinical Trial.
Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study.
Williams B, Lacy PS, Cruickshank JK, Collier D, Hughes AD, Stanton A, Thom S, Thurston H; CAFE and ASCOT Investigators. Williams B, et al. Among authors: cruickshank jk. Circulation. 2009 Jan 6;119(1):53-61. doi: 10.1161/CIRCULATIONAHA.108.785915. Epub 2008 Dec 22. Circulation. 2009. PMID: 19103995 Clinical Trial.
Dietary nitrate prevents progression of carotid subclinical atherosclerosis through blood pressure-independent mechanisms in patients with or at risk of type 2 diabetes mellitus.
Morselli F, Faconti L, Mills CE, Morant S, Chowienczyk PJ, Yeung JA, Cavarape A, Cruickshank JK, Webb AJ. Morselli F, et al. Among authors: cruickshank jk. Br J Clin Pharmacol. 2021 Dec;87(12):4726-4736. doi: 10.1111/bcp.14897. Epub 2021 May 29. Br J Clin Pharmacol. 2021. PMID: 33982797 Free article. Clinical Trial.
Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial.
Brown MJ, Williams B, Morant SV, Webb DJ, Caulfield MJ, Cruickshank JK, Ford I, McInnes G, Sever P, Salsbury J, Mackenzie IS, Padmanabhan S, MacDonald TM; British Hypertension Society's Prevention and Treatment of Hypertension with Algorithm-based Therapy (PATHWAY) Studies Group. Brown MJ, et al. Among authors: cruickshank jk. Lancet Diabetes Endocrinol. 2016 Feb;4(2):136-47. doi: 10.1016/S2213-8587(15)00377-0. Epub 2015 Oct 18. Lancet Diabetes Endocrinol. 2016. PMID: 26489809 Free PMC article. Clinical Trial.
Structure-functional changes in eNAMPT at high concentrations mediate mouse and human beta cell dysfunction in type 2 diabetes.
Sayers SR, Beavil RL, Fine NHF, Huang GC, Choudhary P, Pacholarz KJ, Barran PE, Butterworth S, Mills CE, Cruickshank JK, Silvestre MP, Poppitt SD, McGill AT, Lavery GG, Hodson DJ, Caton PW. Sayers SR, et al. Among authors: cruickshank jk. Diabetologia. 2020 Feb;63(2):313-323. doi: 10.1007/s00125-019-05029-y. Epub 2019 Nov 15. Diabetologia. 2020. PMID: 31732790 Free PMC article.
A randomised, factorial trial to reduce arterial stiffness independently of blood pressure: Proof of concept? The VaSera trial testing dietary nitrate and spironolactone.
Mills CE, Govoni V, Faconti L, Casagrande ML, Morant SV, Crickmore H, Iqbal F, Maskell P, Masani A, Nanino E, Webb AJ, Cruickshank JK. Mills CE, et al. Among authors: cruickshank jk. Br J Clin Pharmacol. 2020 May;86(5):891-902. doi: 10.1111/bcp.14194. Epub 2020 Feb 22. Br J Clin Pharmacol. 2020. PMID: 31833569 Free PMC article. Clinical Trial.
233 results